Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Arch Esp Urol
1 Cancer Res
1 Clin Genitourin Cancer
1 Cochrane Database Syst Rev
1 Eur Urol Focus
2 Int Braz J Urol
1 Int J Infect Dis
1 J Ethnopharmacol
1 J Urol
1 Nat Cell Biol
1 Toxicol Appl Pharmacol
1 Urology

    Arch Esp Urol

  1. VALLEJO-BENITEZ A, Rodriguez-Zarco E, Pabon-Carrasco S, Espinal PS, et al
    [Small cell bladder carcinoma in age extremes: Report of two cases.]
    Arch Esp Urol. 2018;71:204-207.
    >> Share

    Cancer Res

  2. CHEN A, Fu G, Xu Z, Sun Y, et al
    Detection of Bladder Cancer Via Microfluidic Immunoassay and Single-Cell DNA Copy Number Alteration Analysis of Captured Urinary Exfoliated Tumor Cells.
    Cancer Res. 2018 May 22. pii: 0008-5472.CAN-17-2615.
    >> Share

    Clin Genitourin Cancer

  3. KAYAMA E, Kikuchi E, Fukumoto K, Shirotake S, et al
    History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.
    Clin Genitourin Cancer. 2018 Apr 28. pii: S1558-7673(18)30303.
    >> Share

    Cochrane Database Syst Rev

  4. BENNETT MH, Feldmeier J, Smee R, Milross C, et al
    Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Cochrane Database Syst Rev. 2018;4:CD005007.
    >> Share

    Eur Urol Focus

  5. MICHELS CTJ, Wijburg CJ, Leijte E, Witjes JA, et al
    A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research.
    Eur Urol Focus. 2018 May 18. pii: S2405-4569(18)30104.
    >> Share

    Int Braz J Urol

  6. TURAN T, Efiloglu O, Gunaydin B, Ozkanli S, et al
    Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.
    Int Braz J Urol. 2018;44:267-272.
    >> Share

  7. TANG S, Hao H, Fang D, Zheng W, et al
    Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
    Int Braz J Urol. 2018;44:258-266.
    >> Share

    Int J Infect Dis

  8. BILSEN MP, van Meijgaarden KE, de Jong HK, Joosten SA, et al
    A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer.
    Int J Infect Dis. 2018 May 17. pii: S1201-9712(18)34414.
    >> Share

    J Ethnopharmacol

  9. YUEN JWM, Mak DSY, Chan ES, Gohel MDI, et al
    Tumor inhibitory effects of intravesical Ganoderma lucidum instillation in the syngeneic orthotopic MB49/C57 bladder cancer mice model.
    J Ethnopharmacol. 2018 May 18. pii: S0378-8741(18)31199.
    >> Share

    J Urol

  10. MAZZA P, Moran GW, Li G, Robins DJ, et al
    Conservative Management Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.
    J Urol. 2018 May 19. pii: S0022-5347(18)43234-X. doi: 10.1016/j.juro.2018.
    >> Share

    Nat Cell Biol

  11. WEBER C
    A biobank for bladder cancer.
    Nat Cell Biol. 2018 May 21. pii: 10.1038/s41556-018-0114.
    >> Share

    Toxicol Appl Pharmacol

  12. JIN CY, Molagoda IMN, Karunarathne WAHM, Kang SH, et al
    TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.
    Toxicol Appl Pharmacol. 2018 May 21. pii: S0041-008X(18)30233.
    >> Share


  13. TAPIERO S, Helfand A, Kedar D, Yossepowitch O, et al
    Patient Compliance with Maintenance Intravesical Therapy for Non-Muscle Invasive Bladder Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30473.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016